Therapeutic Use Exemptions (TUEs) | World Anti Doping Agency A retroactive TUE provides an athlete the opportunity to apply for a TUE for a prohibited substance or prohibited method after using or possessing the substance or method in question At least one of the five retroactive conditions set out in ISTUE Article 4 1 must be satisfied to apply for a retroactive TUE
TUE Application Form - World Anti Doping Agency The printable and redline versions of the TUE Application Form are also available below You can subscribe to notifications about TUE-related resources by clicking the Subscribe button below If you are already subscribed and would like to unsubscribe, you can contact our Digital specialist at commsupport@wada-ama org
Guidelines for the International Standard for Therapeutic Use . . . The International Standard for Therapeutic Use Exemptions (ISTUE) Guidelines support the ISTUE It takes athletes, Anti-Doping Organizations (ADOs), physicians and athlete support personnel through the TUE process, commencing with a clear understanding that only substances and methods included on the List require a TUE
Therapeutic Use Exemptions - World Anti Doping Agency TUE Application Process Before taking any medication, an athlete must check the status of the medication on the List or with their Anti-Doping Organization (ADO) If the substance is prohibited, the athlete will need to apply for a TUE WADA outlines the rules and process, hears appeals and monitors TUE decisions made by ADOs Athletes do not
International Standard for Therapeutic Use Exemptions (ISTUE) The International Standard for Therapeutic Use Exemptions (ISTUE) is a mandatory International Standard developed as part of the World Anti-Doping Program The purpose of the ISTUE is to establish the conditions that must be satisfied in order for a TUE to be granted, permitting an athlete to use a
TUE Physician Guidelines - Intravenous Infusion - World Anti Doping Agency Therapeutic Use Exemptions (TUE) Physician Guidelines - on Intravenous Infusion All TUE Physician Guidelines are reviewed annually by WADA's TUE Expert Advisory Group to ensure that they remain consistent with good medical practice and WADA standards The date on each TUE Physician Guidelines reflects the last time any revisions were made
TUE Physician Guidelines - Asthma | World Anti Doping Agency The date on each TUE Physician Guidelines reflects the last time any revisions were made You can subscribe to notifications about TUE-related resources by clicking the Subscribe button below If you are already subscribed and would like to unsubscribe, you can contact our Digital specialist at commsupport@wada-ama org Subscribe
THERAPEUTIC USE EXEMPTION GUIDELINES - World Anti-Doping Agency TUE Guidelines January 2012 - 5 - Introduction and scope These Therapeutic Use Exemption (TUE) Guidelines are a model for best practice developed as part of the World Anti-Doping Programme They are based on the World Anti-Doping Code (Code or CODE) and the International Standard for TUEs established through the Code These
Guidelines for the Therapeutic Use Exemptions - World Anti-Doping Agency for a TUE when medical treatment is required involvingthe use of a prohibited substance or prohibited method This process, protecting all clean athletes, promotes competition on a level playing field If a TUE is granted, an athlete may continue, or start to use, the otherwise prohibited substance or method
WADA publishes updated Therapeutic Use Exemption Physician Guidelines . . . TUE Physician Guidelines; TUE Physician Guidelines aim to guide and assist TUE Committees (TUECs) in the decision-making process for TUE applications They include updated guidance on how to evaluate TUE requests for six different medical conditions, such as asthma or musculoskeletal conditions, where GCs may be used